Home4016 • TADAWUL
add
Middle East Pharmaceutical Inds Co SJSC
Previous close
SAR 139.00
Day range
SAR 138.20 - SAR 142.00
Year range
SAR 90.20 - SAR 197.60
Market cap
2.82B SAR
Avg Volume
152.94K
P/E ratio
35.44
Dividend yield
-
Primary exchange
TADAWUL
Market news
Financials
Income Statement
Revenue
Net income
| (SAR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 101.13M | 8.40% |
Operating expense | 39.75M | 23.61% |
Net income | 21.81M | 20.85% |
Net profit margin | 21.56 | 11.48% |
Earnings per share | — | — |
EBITDA | 26.32M | 17.62% |
Effective tax rate | 6.94% | — |
Balance Sheet
Total assets
Total liabilities
| (SAR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.63M | 119.44% |
Total assets | 465.96M | 9.43% |
Total liabilities | 128.80M | -13.16% |
Total equity | 337.15M | — |
Shares outstanding | 20.00M | — |
Price to book | 8.24 | — |
Return on assets | 13.11% | — |
Return on capital | 16.51% | — |
Cash Flow
Net change in cash
| (SAR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 21.81M | 20.85% |
Cash from operations | 10.87M | 2.87% |
Cash from investing | -3.97M | 31.21% |
Cash from financing | -19.80M | -66.20% |
Net change in cash | -12.90M | -81.31% |
Free cash flow | -761.72K | — |
About
Founded
1998
Headquarters
Website
Employees
543
